C-H Wu Selected Research

Long Noncoding RNA

10/2016	Exosomes mediated transfer of lncRNA UCA1 results in increased tamoxifen resistance in breast cancer cells.
1/2016	LncRNA UCA1 promotes epithelial-mesenchymal transition (EMT) of breast cancer cells via enhancing Wnt/beta-catenin signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

C-H Wu Research Topics

Disease

9	Neoplasms (Cancer) 05/2016 - 08/2004
4	Breast Neoplasms (Breast Cancer) 10/2017 - 01/2016
3	Hepatocellular Carcinoma (Hepatoma) 05/2016 - 01/2015
3	Obesity 08/2015 - 05/2008
3	Carcinogenesis 09/2013 - 10/2003
3	Inflammation (Inflammations) 01/2013 - 02/2010
3	Wounds and Injuries (Trauma) 02/2010 - 02/2003
2	Pain (Aches) 01/2017 - 05/2012
2	Carcinoma (Carcinomatosis) 10/2016 - 09/2013
2	Chronic Kidney Failure (Chronic Renal Failure) 10/2015 - 06/2010
2	Hypertension (High Blood Pressure) 08/2015 - 05/2008
2	Chronic Hepatitis C 04/2013 - 01/2006
2	Insulin Resistance 04/2013 - 05/2008
2	Necrosis 01/2013 - 05/2012
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2008 - 02/2008
1	Bone Resorption 04/2020
1	Osteoporosis 04/2020
1	Hip Fractures (Intertrochanteric Fractures) 04/2020
1	Ischemic Stroke 10/2019
1	Critical Illness (Critically Ill) 10/2019
1	Pancreatic Fistula (Pancreatic Fistulas) 01/2019
1	Fistula 01/2019
1	Persistent Infection 10/2018
1	Crush Injuries 10/2018
1	Cholangiocarcinoma 05/2016
1	Chronic Renal Insufficiency 10/2015
1	Dyslipidemias (Dyslipidemia) 08/2015
1	Hyperglycemia 08/2015
1	Weight Loss (Weight Reduction) 05/2015
1	Viremia 12/2014
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 05/2014
1	Varicose Veins (Varicose Vein) 04/2013
1	Fibrosis (Cirrhosis) 04/2013
1	Postoperative Pain 04/2013
1	Neoplasm Metastasis (Metastasis) 01/2013
1	Lung Neoplasms (Lung Cancer) 01/2013
1	Left Ventricular Dysfunction 01/2013
1	Infarction (Infarctions) 01/2013
1	Myocardial Infarction 01/2013
1	Hyperalgesia 05/2012
1	Cerebral Hemorrhage 08/2011

Drug/Important Bio-Agent (IBA)

3	Factor VII (Proconvertin)IBA 02/2016 - 05/2014
3	CytokinesIBA 02/2015 - 05/2012
3	Proteins (Proteins, Gene)FDA Link 05/2014 - 11/2005
2	Death-Associated Protein KinasesIBA 10/2017 - 03/2016
2	Freund's AdjuvantIBA 01/2017 - 05/2012
2	Long Noncoding RNAIBA 10/2016 - 01/2016
2	MicroRNAs (MicroRNA)IBA 03/2016 - 09/2013
1	romosozumabIBA 04/2020
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 04/2020
1	Pain-FreeIBA 10/2018
1	K Cl- CotransportersIBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2017
1	Histones (Histone)IBA 01/2017
1	Analgesics (Analgesic Drugs)IBA 01/2017
1	Histone Deacetylase InhibitorsIBA 01/2017
1	Tamoxifen FDA LinkGeneric 10/2016
1	Estrogen ReceptorsIBA 10/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2016
1	CateninsIBA 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2016
1	Pentoxifylline (Trental)FDA LinkGeneric 10/2015
1	Monoamine Oxidase (MAO)IBA 08/2015
1	1- (2,4- dichlorophenyl)- 4- ethyl- 5- (5- (2- (4- (trifluoromethyl)phenyl)ethynyl)thiophen- 2- yl)- N- (piperidin- 1- yl)- 1H- pyrazole- 3- carboxamideIBA 05/2015
1	Glycogen Synthase (Synthase I)IBA 02/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2015
1	trans-sodium crocetinate (crocetin)IBA 01/2015
1	Indicators and Reagents (Reagents)IBA 01/2015
1	Ribavirin (Virazole)FDA LinkGeneric 12/2014
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 05/2014
1	Thromboplastin (Tissue Factor)IBA 05/2014
1	PAR-2 ReceptorIBA 05/2014
1	Insulin ReceptorIBA 09/2013
1	Insulin Receptor Substrate ProteinsIBA 09/2013
1	Somatomedin Receptors (Somatomedin Receptor)IBA 09/2013
1	PhytochemicalsIBA 01/2013
1	ResveratrolIBA 01/2013
1	Toll-Like Receptor 4IBA 01/2013
1	Carvedilol (Coreg)FDA LinkGeneric 01/2013
1	beta-Arrestin 1IBA 01/2013
1	NF-kappa B (NF-kB)IBA 01/2013
1	CannabinoidsIBA 05/2012
1	Interleukin-6 (Interleukin 6)IBA 05/2012
1	AM 1241IBA 05/2012
1	antithrombin III-protease complexIBA 08/2011
1	Thrombin FDA Link 08/2011

Therapy/Procedure

4	Therapeutics 03/2016 - 04/2013
2	Transplantation 05/2016 - 06/2010
2	Highly Active Antiretroviral Therapy (HAART) 01/2010 - 05/2009
1	Central Venous Catheters 10/2019
1	Enteral Nutrition (Feeding, Tube) 01/2019
1	Pancreaticoduodenectomy 01/2019
1	Length of Stay 01/2019
1	Free Tissue Flaps 10/2018
1	Arthrodesis 10/2018
1	Surgical Amputation (Amputations) 10/2018
1	Liver Transplantation 05/2016
1	Hepatectomy 05/2016
1	Electroacupuncture 05/2012